Kaitlin Jansen

Writing and media relations at @DCRINews; sharing knowledge gained through innovative clinical research that improves the care of patients around the world

[Kaitlin Jansen @Kaitlin_DCRI]

Hi @MarilynnL, trying to get in touch regarding a correction to a recently published story. Would you be so kind as to DM me? Thank you!

[Kaitlin Jansen @Kaitlin_DCRI]

.@DCRINews announced today that Adrian Hernandez (@texhern) will be its new leader. Hernandez says his focus for the DCRI's future will be on "more efficient studies and creating new pathways for innovative health solutions and groundbreaking research." https://t.co/n8hjRLyJ3k

[Duke Clinical Research Institute @DCRINews]

Welcome to DCRI’s New Executive Director | Adrian Hernandez, a cardiologist and internationally recognized #clinicalresearch expert, has been named as the DCRI’s new leader. Learn more about @texhern’s vision: https://t.co/t4fabtyRJt

[Kaitlin Jansen @Kaitlin_DCRI]

The HERO Registry, which seeks to enroll thousands of #HealthCareWorkers, launched today. Sign up to share your perspectives and help find solutions for those on the #COVID19 #pandemic front lines. @HeroesResearch https://t.co/G78gY1vsr8

[Duke Clinical Research Institute @DCRINews]

Launching today | DCRI-led #HERORegistry inviting US #healthcareworkers to share clinical & life experience in order to understand perspectives & problems faced by those on #COVID19 #pandemic front lines. More: https://t.co/tchDFK9uT4 | @HeroesResearch @PCORI

[Kaitlin Jansen @Kaitlin_DCRI]

This just in: @PCORI Board of Governors has approved up to $50M for this important DCRI-led research program. The first trial will examine whether #Hydroxychloroquine is effective in preventing #COVID19 infection in #healthcare workers. Read more: https://t.co/i8OmS7pgAP

[Duke Clinical Research Institute @DCRINews]

DCRI will lead a rapid-response registry of #healthcare workers and a #clinicaltrial to test #HCQ as a potential #COVID19 prevention strategy for these workers at high risk of contracting #coronavirus. Both projects are funded by @PCORI. More: https://t.co/CSwyGyfsgI

[Duke Clinical Research Institute @DCRINews]

#NationalDoctorsDay | Watch as several DCRI faculty share why they became doctors & how their commitment to #patientcare dovetails w/ their #research. THANK YOU to all of our physician-researchers for all you do, TODAY & EVERY DAY. See the full video here: https://t.co/QfYEOdClUc

[Duke Clinical Research Institute @DCRINews]

#ACC20 #WCCardio | AUGUSTUS secondary analysis weighs risks and benefits of #aspirin therapy in specific patient population -- full story: https://t.co/hZXNrAAFTt | @ACCinTouch @worldheartfed @jha7566 @RenatoDLopes1

[Kaitlin Jansen @Kaitlin_DCRI]

Congratulations to @cpcresearch on VOYAGER PAD results presented this morning at #ACC20. DCRI's @manesh_patelMD, a member of the study's SC, reflects on all of the collaborative work the DCRI has conducted over the years to find optimal treatment strategy for patients w/ PAD.

[Duke Clinical Research Institute @DCRINews]

Findings presented as a #LBCT at #ACC20 | #WCCardio & published simultaneously in @NEJM from VOYAGER PAD reveal a promising treatment strategy for patients w/ #peripheralarterydisease undergoing revascularization: https://t.co/MhZh8ZvyFO | #PAD | @ACCinTouch @worldheartfed

[Kaitlin Jansen @Kaitlin_DCRI]

How has #covid19 already affected #clinicalresearch, and what will the continued impacts be? @DCRINews' @texhern & @snaggie1, along with @DukeForge's @eperakslis addressed this and more at @Collaboratory1 Grand Rounds: https://t.co/MEpeHey0NF

[Kaitlin Jansen @Kaitlin_DCRI]

The DCRI's new Pediatric #Migraine Registry, which enrolled 200 patients in a little over a year, could provide much-needed data to investigators, #pharma companies, and more. https://t.co/E4XH3hYyJs

[Duke Clinical Research Institute @DCRINews]

A new registry established by the DCRI seeks to answer critical questions for #pediatric patients who experience #migraines, while providing a potential pathway for future #drugdevelopment to help these patients: https://t.co/RrSPUPVTt8

[Kaitlin Jansen @Kaitlin_DCRI]

"What role does an academic research organization play in the #digitalhealth explosion?" See how the DCRI is working to help develop and validate #digitaltherapeutics: https://t.co/JfsFNh4bEt

[Duke Clinical Research Institute @DCRINews]

DCRI and Digital Solutions: A New World of Evidence Generation | From thought leadership on a national stage to driving adoption for #digitalhealth technologies, the DCRI is leading the way in the #digitaltherapeutics space. See how: https://t.co/vbDMjTdtGC

[Kaitlin Jansen @Kaitlin_DCRI]

In @JACCJournals, DCRI's @RenatoDLopes1 calls for system-wide change in the #clinicaltrials ecosystem, incl. a renewed focus on #RWD, so that more studies can be conducted at a lower cost. https://t.co/vzaSLX9uq2

[Kaitlin Jansen @Kaitlin_DCRI]

A recent @CircAHA paper, the result of a #DCRIThinkTank, examines @US_FDA guidance for #diabetes drugs and calls for a less stringent approval process to improve access for patients. https://t.co/6upQu9n7RL

[Kaitlin Jansen @Kaitlin_DCRI]

In recognition of #HeartMonth, DCRI is highlighting our impressive #cardiovascular work, made even stronger by collaborations with DCRI's 7 other therapeutic areas. Follow along at @DCRINews all month to see our work that considers not only the heart, but the whole patient.

[Duke Clinical Research Institute @DCRINews]

DCRI started with the #heart. For decades, our work has changed practice to improve care for patients with heart conditions. Today, our #cardiovascular faculty build on that legacy. And we’ll be celebrating their work throughout #HeartMonth: https://t.co/XUhNuxsFui

[Kaitlin Jansen @Kaitlin_DCRI]

Despite results from FOURIER & ODYSSEY, both major #PCSK9 #clinicaltrials, prescription volume & approval rates for this lipid-lowering therapy remain low. Still, DCRI's @AnnMarieNavar is optimistic about future adoption that will improve access for patients.

[Duke Clinical Research Institute @DCRINews]

A new study from the DCRI demonstrates continued challenges for the adoption of #PCSK9 inhibitors for patients who need additional lipid-lowering therapy beyond #statins. @AnnMarieNavar & @ericpetersonMD published findings in @CircOutcomes: https://t.co/CNoyj6uwxZ

[Kaitlin Jansen @Kaitlin_DCRI]

Recent DCRI research provides clinical evidence that a video game-based app may improve #ADHD symptoms both for children taking #ADHD medication & for children using only the app.

[Duke Clinical Research Institute @DCRINews]

Evidence from a recently completed DCRI-led #clinicaltrial supports hypothesis that an investigational #digitaltherapeutic may be an effective treatment for children w/ #ADHD. https://t.co/LSeYUfkGeF | #DTx @skollins1

[Kaitlin Jansen @Kaitlin_DCRI]

Although survival rates after sudden #cardiacarrest did not differ significantly for patients on #dialysis, this DCRI-led study revealed opportunities to improve #resuscitation care for these patients.

[Duke Clinical Research Institute @DCRINews]

A DCRI study leveraged #RWD from an @American_Heart registry to determine whether patients on #dialysis experienced worse #resuscitation care after #cardiacarrest. See results here: https://t.co/5hd5aNFbHZ

[Kaitlin Jansen @Kaitlin_DCRI]

The DCRI delivers on its mission to share knowledge not only via primary trial results, but also secondary manuscripts that leverage the same data to answer addtl. Qs. Studies using data from EXSCEL incl. @texhern, @robmentz, & other DCRI investigators. https://t.co/aeHh7xcvAe

[Kaitlin Jansen @Kaitlin_DCRI]

.@MichaelGNanna and @ericpetersonMD respond to a study that found 80% of patients with prior #MI are eligible for 4+ novel therapies. They call for renewed focus on adoption of these therapies, noting that using the #EHR to identify eligible patients is an exciting opportunity.

[Duke Clinical Research Institute @DCRINews]

A recent editorial in @JAMACardio by DCRI’s @MichaelGNanna & @ericpetersonMD calls for novel strategies that focus on adoption of new #CV therapies for #secondaryprevention. https://t.co/VB4oNNwgUA #implementationscience

[Kaitlin Jansen @Kaitlin_DCRI]

New #stroke study from DCRI's @Shree_Stroke uses #RWE from @American_Heart's Get With The Guidelines-Stroke registry to highlight the differences between guideline recommendations & clinical practice, as well as underscore the need for individualized treatment decisions.

[Duke Clinical Research Institute @DCRINews]

New analysis in @CircOutcomes by DCRI’s @Shree_Stroke & Ying Xian found that patients who have experienced a #stroke in the two weeks prior to being treated with #IVtPA have a higher risk for symptomatic #intracranialhemorrhage. More: https://t.co/Q9G51HAQkr #ischemicstroke

[Kaitlin Jansen @Kaitlin_DCRI]

Drawing on our expertise in #medicaldevice trials, @DCRINews led the first trial to use a common protocol to study a #CV device in both the U.S. and Japan. Trial results recently led to regulatory approval of the stent in Japan. More: https://t.co/ygzyTaMaPt